Skip to content

Laser Speckle Contrast Imaging for Cutaneous Microvascular Dysfunction Detection in Systemic Sclerosis.

Laser SPEckle Contrast Imaging Interest in dEtection of Cutaneous Microvascular Dysfunction in Systemic Sclerosis.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01743612
Acronym
SPECIES
Enrollment
101
Registered
2012-12-06
Start date
2012-01-31
Completion date
2015-06-30
Last updated
2016-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Raynaud Disease, Scleroderma, Systemic

Keywords

healthy subject, hand blood flow, laser speckle contrast imaging

Brief summary

The aim of the study is to determine if postocclusive hyperemia of palmar and dorsal face of the hand with Laser speckle contrast imaging discriminate between patients with systemic sclerosis, subjects with primary Raynaud's phenomenon and healthy subjects.

Detailed description

Microvascular dysfunction is a key event in the pathogenesis of systemic sclerosis. There are currently no test measuring it in clinical practice. Response to humeral occlusion is interesting and this response has been studied with laser Doppler flowmetry. More recently, laser imaging has been used analysing the granularity of the laser: laser Speckle Contrast Imaging which allow combining high temporal resolution to high spatial resolution. The investigators proposed, in this study, to compare this imaging at basal and after post-occlusive hyperaemia of dorsal and palmar face of hand in 3 groups: healthy subjects, primary Raynaud's phenomenon and systemic sclerosis.

Interventions

blood flow recording during 30 minutes after 2 post-occlusive hyperaemia of 5 minutes separated by 30 minutes.

PROCEDURECooling

blood flow of the hand recording during 30 minutes in a cooling-box

Sponsors

University Hospital, Grenoble
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Healthy subjects: * Man ou woman 18 years old or more. * Without Raynaud's phenomenon or systemic sclerosis. Raynaud's phenomenon subjects: * Man ou woman 18 years old or more. * with primary Raynaud's phenomenon. Systemic sclerosis: * Man ou woman 18 years old or more. * systemic sclerosis in accordance to Leroy's classification.

Exclusion criteria

* active digital ulceration * Bosentan, iloprost ou sildenafil treatment * History of axillary dissection , trauma or surgery * history of thromboembolic disease or thrombophilia * minor or law-protected major * exclusion period in another study * No affiliation to medicare * pregnant, parturient or breasting woman * concomitant serious disease: progressive cancer, liver failure, history of myocardial infarction less than 5 years, angor * smoking in the 6 last months * person deprived of liberty by a legal or administrative decision, person under legal protection * maximal annual indemnification reached.

Design outcomes

Primary

MeasureTime frameDescription
Post-occlusive hyperemia response between groups30 minutesThe range of post-occlusive hyperemia response will be compared between the 3 arms.

Secondary

MeasureTime frameDescription
abnormal post-occlusive hyperemia response and finger pad scars30 minutescomparison of range of post-occlusive hyperemia response with or without finger pad scars.
post-occlusive hyperemia response between zones30 minutesThe range of post-occlusive hyperemia response will be compared between zones.
Entropy and Fourier transform30 minutesThe interest of the signal analyses to distinguish systemic sclerosis, raynaud's phenomenon and healthy subjects will be studied with entropy and Fourier transform.
Post-occlusive hyperemia response between the 2 faces30 minutesThe Range of post-occlusive hyperemia response will be compared between the 2 hand faces (palmar and dorsal).

Other

MeasureTime frameDescription
blood flow after cooling in each group30 minutesThe range of blood flow after cooling on pulpar and dorsal face of hand will be compared between the 3 groups.
reproductibility of hand coolingDay 0 and Day 4The reproductibility of the measure of blood flow after cooling will be studied twice, at day0 and 4 days later.
Blood flow after cooling between groups30 minutesRange of the diminution of blood flow in palmar and dorsal hand faces will be compared in the 3 groups

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026